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1 Introduction
In 1917 SLEMONS and BOGERT [8] were the first to
report an association between serum uric acid
(SUA) levels and preeclampsia (PE) and in 1934
STANDER and CADDEN [9] first demonstrated a
correlation between SUA concentration and the
severity of PE. Since then numerous articles have
been published which conclude that elevated ur-
icemia in hypertensive pregnancies is associated
with poor perinatal results.
The mechanism that produces this elevation of
SUA concentration has not been clearly defined
yet, but as SAGEN [6] and DUMONT [2] have sug-
gested, it may result from increased blood lactate
levels due to anaerobic metabolism of the
uteroplacental unit. An increased SUA concentra-
tion may also be affected by impaired uric acid
clearance caused by maternal hemoconcentration
[4]-
The aim of our study was to analyze the possible
correlation between the highest levels of SUA
observed in hypertensive pregnant patients during
the third trimester of gestation, the severity of PE
and the perinatal outcome.
2 Material and methods
Maximum concentrations of uricernia were se-
lected in 215 hypertensive pregnant women during
the third trimester of pregnancy. Of these 215
patients, 100 had mild PE, 25 had severe PE, 70
had essential hypertension (EH) and 20 had EH
and superimposed PE (EH + PE). We categorized
hypertension in pregnancy as mild in the range
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140/159 torr systolic and 90/99 torr diastolic and
as severe if blood pressure equalled or exceeded
160 torr systolic and 100 torr diastolic.
Mean uricemia and the occurrence of SUA levels
of 6 mg% or higher were estimated for each group
of patients. The results obtained were then corre-
lated with perinatal results.
3 Results
Table I demonstrates mean SUA levels for each
group. SUA values were significantly higher in
patients with severe PE and with EH + PE when
compared with the other groups.
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Analysis of variance p < 0.05 SP vs MP vs EH
EH + PE vs MP vs EH }P<0·05
Table II. Occurrence of uricemia ^ 6 mg% during the third trimester of gestation in hypertensive pregnant women.
Uricemia Preeclampsia Hypertension




































p < 0.05 MP vs SP vs EH + PE
EH vs EH + PE p < 0.05
Table ΙΠ. Uricemia in pregnancy hypertension: perinatal results
Preeclampsia Hypertension
Mild Severe Essential Essential + preeclampsia
Mean gestational age at
delivery (weeks)
Occurence of low birth weight













For occurence of low birth weight = MP vs EH + ΡΕ ρ < 0.05 (χ2)
For mean birth weight and gestational age = MP vs SP vs EH + ΡΕ Ί
SP vs EH vs EH + PE > ρ < 0.05 analysis of variance
EH vs EH + PE J























Independence test ρ < 0.05 N.S.
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The proportion of patients with SUA concentra-
tions of 6 mg% or higher was significantly greater
in women with severe PE and with EH + PE than
in those with mild PE and EH (table II).
Gestational age at delivery and mean birth weight
were found to be significantly lower, and low birth
weight for gestational age significantly higher, in
the severe PE and EH + PE groups than in the
remaining groups (table III).
When the patients in each of the groups were
analyzed in terms of uricemia equal to or higher
than 6 mg%, no correlation could be found be-
tween SUA levels and birth weight (table IV).
4 Discussion
REDMAN et al [5], FADEL et al [3] and VARMA [10]
reported that SUA levels for PE patients were
markedly elevated as compared with EH women,
whose uricemia was in turn higher than in normal
pregnant women.
Our study demonstrates that mean SUA concen-
tration is significantly higher in severe PE (6.22
mg% ± 1.30 mg%) and EH + PE patients (6.09
mg% ± 1.53 mg%) than in mild PE (4.85 mg%
± 1.34 mg%) and EH patients (4.95 mg% ± 1.22
mg%), where uricemia is higher than in normal
pregnancy (3.99 mg% ± 0.99 mg%) but still well
below that in severe PE and EH + PE cases.
Several authors [1, 3, 4, 5, 6, 7, 10] have stated
that hyperuricemia associated with a hypertensive
pregnancy increases the incidence of intrauterine
growth retardation, low birth weight and severe
fetal distress.
VARMA [10] noted that in mild hypertension the
prognosis for the fetus is affected. Our findings,
when mean SUA levels and mean birth weight in
all the groups were considered together, agreed
with those reported by VARMA. When SUA levels
and birth weight were studied within each group,
no significant correlation was found. In our study,
hyperuricemia was closely related to the severity
of hypertension, and we did not find high SUA
levels in women with mild hypertension.
We conclude that the determination of uric acid
levels for the clinical screening of pregnancy com-
plicated by hypertension is an easy and inexpen-
sive method useful for the evaluation of perinatal
results which are associated with the severity of
the preeclamptic syndrome.
Summary
Maximum serum uric acid (SUA) levels during the third
trimester of pregnancy were selected in 215 hypertensive
pregnant women: 100 with mild preeclampsia (PE), 25
with severe PE, 70 with essential hypertension (EH) and
20 with EH with superimposed PE (EH + PE). The
increase in SUA levels was statistically significant in
women with severe PE (6.22 mg% ± 1.30 mg%) and
with EH + PE (6.09 mg% ± 1.53 mg%) when com-
pared with values in mild PE and EH women (4.85 mg%
± 1.34mg% and 4.95 mg% ± 1.22 mg%, respectively).
Keywords: Clinical study, preeclampsia, uric acid levels.
A significant decrease in average gestational age at deliv-
ery and a greater percentage of small-for-gestational age
newborns were observed in women with severe PE and
EH + PE, compared with patients with mild PE and
EH. No correlation within the groups was found be-
tween SUA levels and fetal weight.
To conclude, the determination of SUA concentration
for the clinical screening of a pregnancy complicated by
hypertension is an easy and inexpensive method for the
prediction of perinatal results associated with severe PE.
Zusammenfassung
Der Harnsäurespiegel als brauchbarer Parameter für den
Schweregrad einer Präeklampsie und seine prognostische
Bedeutung
Bei 215 hypertonen Schwangeren im letzten Trimenon
wurden die Maxima der Harnsäurespiegel in Beziehung
zum Grad der Eklampsie gesetzt. Dabei lagen bei 100
Frauen eine leichte und bei 25 eine schwere Präeklampsie
vor. 70 Frauen hatten eine essentielle Hypertonie und
20 eine essentielle Hypertonie mit Pfropfgestose. Der
Anstieg des Harmsäurespiegels war bei den Frauen mit
schwerer Präeklampsie sowie mit essentieller Hypertonie
plus Pfropfgestose signifikant (6.22 mg% ± 1.30 mg%
bzw. 6.09 mg% ± 1.53 mg%). Bei den Frauen mit
leichter Präeklampsie und essentieller Hypertonie betru-
gen die Maxima 4.85 mg% ± 1.34 mg% bzw. 4.95 mg%
± l .22 mg%. Bei schwerer Präeklampsie und essentieller
Hypertonie plus Propfgestose war das durchschnittliche
Schwangerschaftsalter bei Entbindung geringer und der
Prozentsatz der Small-for-date-Kinder größer als in den
beiden anderen Gruppen. Innerhalb der Gruppen gab
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es keine Korrelation zwischen Harnsäurespiegel und fe-
talem Gewicht.
Wir meinen, daß die Bestimmung der Harnsäure im
Screening bei Schwangerschaften mit erhöhtem RR eine
einfache und billige Methode darstellt, um perinatale
Probleme im Zusammenhang mit einer schweren Prä-
eklampsie zu erkennen.
Schlüsselwörter: Harnsäurespiegel, klinische Studie, Präeklampsie.
Resume
Taux d'acide urique: une donnee utile pour determiner
la severite du syndrome preeclamptique et du pronostic
perinatal
On a choisi les taux maximum d'acide urique serique
pendant le troisieme trimestre de la grossesse chez 215
femmes enceintes hypertendues. Parmi les 215, 100
avaient une pre-eclampsie (P. E.) legere, 25 avaient une
P. E. severe, 70 presentaient une hypertension essentielle
(HE) et les autres 20: HE avec PE surajoutee (HE + PE).
Uaugmentation des taux d'acide urique a etc statistique-
ment significative chez les femmes avec une PE severe
(6,22 mg% ± 1,30 mg%) et chez les femmes avec
HE~+ PE (6,09 mg% + 1,53 mg%), comparee avec les
valeurs chez les femmes atteintes d'une PE legere et HE
Mots-cles: Acide urique, etude clinique, preeclampsie.
(4,85 mg% ± 1,34 mg% et 4,95 mg% ± 1,22 mg%
respectivement). II a etc observe une diminution remar-
quable de Page de gestation moyen au moment de P ac-
couchement, ainsi qu'une plus grande incidence de
nouveaux-nes petits pur leur äge de gestation chez les
femmes souffrant d'une PE severe et de HE + PE, en
comparaison avec celles avec une PE legere et HE.
Aucune correlation n'a ete trouvee entre les taux seriques
d'acide urique et le poids foetal dans tous les groupes.
On en deduit que la determination du taux d'acide
urique pour Petude clinique de la grossesse, compliquee
d'hypertension, est une methode facile et de coüt faible
pour predire les resultats perinatals associes a la PE
severe.
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